AK

Alexandra Kropotova

Chief Medical Officer, EVP

SAB Biotherapeutics

Philadelphia, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
SAB Biotherapeutics
Industry
research
Employees
64.0
Seniority
C suite
Annual Revenue
1322000.0

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Google Tag Manager Google Font API WordPress.org Typekit Mobile Friendly Gravity Forms Nginx Google Analytics Bootstrap Framework

Keywords

biotechnology: biological products (no diagnostic substances) health care biotechnology research sab-142 disease-modifying therapy type 1 diabetes immunotherapy immunoglobulins clinical trials autoimmune disorders beta cells immune response modulation chronic disease management redosable therapy safety profile antibody therapy insulin preservation t-lymphocytes targeting clinical development immune system novel therapies treatment options human antibodies therapeutic areas regulatory t-cells c-peptide preservation hba1c reduction immune-mediated diseases healthcare innovation biopharmaceuticals genetic engineering patient care solutions quality of life research & development therapeutic pipelines fda approval immune modulation disease trajectory biotech investments patient safety collaborative healthcare immune tolerance clinical evidence ongoing research patient-centric treatments health challenges scientific breakthroughs biotech company novel imunotherapy anti-thymocyte globulin protocols healthcare solutions biopharma leadership health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans